Sermorelin.com Unveils Telehealth Peptide Treatment for Lean Mass Preservation Sheridan, United States February 27, 2026 / Sermorelin.com / SHERIDAN, WY Sermorelin.com, a telehealth platform focused on physician-supervised peptide therapy, has announced the introduction of a new clinical initiative aimed at assisting patients who are undergoing treatment with GLP-1 receptor agonist medications in maintaining their lean body mass
Liraglutide works by mimicking the hormone GLP-1 to help you feel fuller and reduce the amount of food you eat
Semaglutide does not alter nutrient absorption, but certain bariatric surgeries can
He has been a principal investigator for industry-sponsored clinical trials run by Novo Nordisk, Sanofi, Bayer, Johnson-Cilag and AbbVie
So, the personalized label wont save you